Cargando…
Anti-CD3 monoclonal antibody as a possible therapeutic alternative in HAM/TSP
Autores principales: | Van Weyenbergh, Johan, Decanine, Daniele, Schnitman, Saul Velloso, Moro, Ana Maria, Kalil, Jorge, Kruschewsky, Ramon A, Galvão-Castro, Bernardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044874/ http://dx.doi.org/10.1186/1742-4690-11-S1-O40 |
Ejemplares similares
-
Monocyte accumulation is an early event in HAM/TSP pathogenesis, while monocyte activation and IFN-regulated gene expression persist in chronic HAM/TSP
por: Menezes, Soraya Maria, et al.
Publicado: (2015) -
A selective defect in Fas-mediated apoptosis in HAM/TSP: An ex vivo, in vitro and in silico study
por: Menezes, Soraya Maria, et al.
Publicado: (2014) -
B cell costimulatory molecules as potential biomarkers in HAM/TSP
por: Menezes, Soraya M, et al.
Publicado: (2011) -
HTLV-1 proviral load of HAM/TSP patients according to new diagnostic criteria of HAM/TSP
por: Grassi, Maria F R, et al.
Publicado: (2011) -
Ascorbic acid has superior antiviral and antiproliferative effects over IFN-alpha in HAM/TSP PBMC ex vivo
por: Moens, Britta, et al.
Publicado: (2011)